Christopher D. Alafi, Director, 10% Owner at Intra-Cellular Therapies, Inc. (ITCI), bought 35,000 shares at $14.75 ($516K) on 2014-11-28, disclosed to the SEC on 2014-11-28.
Open-market purchase of $516k ITCI by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ITCI | BUY | 2020-09-14 | $1.5M | — | Filing → |
| ITCI | BUY | 2020-09-11 | $590K | — | Filing → |
| ITCI | BUY | 2019-09-11 | $9.8M | — | Filing → |